Lung Cancer Update cover image

Striving for Consensus on the Management of ALK-Positive Lung Cancer

Lung Cancer Update

00:00

Is There a Difference Between on Target Resistance and Off Target Resistance?

Ross: Would somebody who progressed after a year and a half make you nervous that maybe something else is going on? Justin: We need to draw a distinction between clear evidence of benefit and then the development of resistance. Ross: I'm curious how you approach patients who are non-smokers and yet on next generation sequencing don't have anything. What about RNA sequencing, other assays and when you do that what do you find?

Play episode from 36:44
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app